BioNTech cuts sales forecast on slumping demand for COVID-19 vaccine

EarningsNegative

AI Analysis

Summary

BioNTech cut its sales forecast by approximately 20% due to declining COVID-19 vaccine demand across all markets, with particularly acute pressure in Germany.

Financial Highlights

Guidance

sales forecast midpoint lowered by almost 20%

Outcome Details

Sales forecast lowered by approximately 20% due to slumping COVID-19 vaccine demand

Importance:6/10

Sentiment:

-0.80

COVID-19vaccinedemand declineguidance reductionGermany

Related Companies

$BNTX

Read the original article

Published by BioSpace on August 4, 2026 2:50 PM

Read Original